|Home Page : www.otcjournal.com
Email Questions or Comments To: firstname.lastname@example.org
OTC Journal Members:
This is the Sperry Univac.
This is considered the first commercial computer, and it came out in 1951. It took up an entire room, and had computing power probably equivalent to the calculator on your desk.
I'll never forget a TV demonstration when I was just a kid. The operator asked it some question, and the machine went through a whole bunch of paper cards, and in the end spit one out with the answer. It took some time.
Obviously, we've come a long ways from this giant series of machines in 1951 (two years before I was born), to today's computing power.
Sperry Univac eventually became Unisys, one of the 12 computer manufacturers in the 60's, all of whom were dwarfed by the achievements of IBM.
Today, we still have gigantic rooms filled with computers known by various names- Server Farms, Cloud Computing, Data Centers, Enterprise Systems. At work, you might have a terminal on your desk, but somewhere along the line there is a giant room full of computers that helps your terminal work. This also applies to your cell phones, Television, and video games, and just about everything electronic.
These gigantic data centers use 10 to 100 times the energy with electricity and cooling. There's a whole energy business just for the proper management of the energy use for data centers. Today's idea has just recently grown from zero to over $50 million in annual revenues in this sector, and absolutely- and I mean absolutely nobody knows about or is following this stock- until now. You are the first investors to actually pay any attention to this situation, which gives you the "first mover" advantage.
On the "What They Do" side I'm really going to keep this short and sweet. MMED is a holding company that has 3 separate companies under its umbrella. Two of the acquisitions have been completed this one- one today after the market closed.
In short, despite there only being about 7.5 million share I&O, MMED, with the acquisitions of Consesus, WeatherWise, and the original subsidiary UtilliPoint, is now a global IT solutions company with over 700 customers and over $50 million in annual revenues. The cap structure of 7.5 million shares is almost silly for a company with this kind of revenue number.
Here's an abbreviated customer list:
Since there's over 700 of them, this list could go on for a while. But, I won't bore you with that stuff. The far more interesting question? What can this stock do? Answer- I have no idea, but I suspect it's going to be a little crazy.
For all intents and purposes, MMED has never really traded. It's almost more like an IPO. It was originally structured as a holding company for IT solutions corps, this year it has delivered a complete transformation.
There was a $1.5 million financing done by a mid tier brokerage firm for the MMED- are you ready for this- priced at $5. The merger with Consensus brought in some shareholders from a private company that own their shares in the $3.50 to $5 range.
The most current audited financials show only $1 million in revenues. However, the Consensus acquisition took place earlier this year, and the acquisition of WeatherWise took place today. You have to really dig into the SEC filings to understand this company has 700 customers and over $50 million in trailing revenues.
For those who want to educate themselves, go to this SEC filing, read it, and you'll get an understanding of the scope of the company's combined:
With today's coverage and others coming behind me, MMED is now officially come "Out of the Closet", and I don't mean that in the controversial way you might be thinking. The company is now really big for their piddly $15 million market value, and we're lucky enough to have been chosen to be first to realize the enormity of what's happened here.
MMED last traded exactly 100 shares at $2.01 yesterday. The financing was done at $5. The Consensus shareholders are in somewhere from $3.50 t0 $5.
Today, after the market closed, MMED announced it acquired WeatherWise Holdings- a complimentary software company. It's rather obvious this company is on a roll this year.
However, check out the chart.
This chart has no technical value. The only thing one can learn from this chart is that this stock has never really traded. The chart actually goes back to May of 2010, and the highest volume day on the chart is 2000 shares.
So, if you could buy this stock for yesterday's print of $2, I would advise you to pick up every share you can afford.
I believe this stock is an absolute must own up to about $3.50, but I'm just guessing where it might go. When it opens tomorrow and has a whole new giant audience, I'm hoping there's some supply you can get.
As with the last idea- VRNG- I cautioned waiting a day or two on a big move up, and if you traded it with some common sense, you ended up 44% in ten days. If jumped it at the top on the first day, you were only up 10%. That's a big difference.
I'm planning some follow up editions to give you a better idea of what this company does. This one is very exciting from a valuation perspective. Next week we'll also have some perspective on how the stock has traded.
In the meantime, this is definitely one to own. Just use some common sense tomorrow. If the price is too crazy, just wait a day. Use a limit order- under the new rule, the size on all orders is now displayed. I would file limit orders right up to $3.50 without too much fear. Then, hang on. This one could get pretty wild.
Here's today's news release:
The OTC Journal Newsletter is an electronic publication committed to providing our readers with useful information on publicly traded companies. The Newsletter contracts with publicly traded companies and receives compensation from them or third parties as payment for publishing information and opinions about the company and the trading market for their securities. Principals of the Newsletter may also purchase or sell securities of the companies in the open market from time to time. The positions, if any, that the Newsletter or its principals presently maintain in the securities of the companies are disclosed here (click here) and should be considered in making an investment decision regarding these companies securities. The Newsletter and its principals reserve the right to acquire additional shares or liquidate some or all of the positions they may hold in the issuer’s securities at any time in the future without further notice. These publications should not be considered to be independent publications concerning the company.
All statements and opinions expressed herein are those of the editors and are subject to change without notice. The Newsletter maintains editorial control over its publications and the companies profiled therein do not have any editorial rights concerning the information published about them. While we believe all sources of information provided by us and contained in our publication to be accurate and reliable, we cannot and do not guarantee the accuracy of information we received from third parties.
The information found in this profile is protected by the copyright laws of the United States and may not be copied, or reproduced in any way without the express written consent of the editors of otcjournal.com.